– USA, MA – Massachusetts Biotechnology Council (aka MassBio) today announced the appointment of Kendalle Burlin O’Connell as the new CEO and President. She has served MassBio’s membership for 14 years, most recently as President & COO.
“Kendalle has been instrumental in building MassBio and positioning our organization for continued growth. Over the past several years, she has proven that she is the leader we need to strengthen and protect one of the state’s most important industries,” said Board chair, Pam Randhawa.
About Kendalle Burlin O’Connell
As President and CEO, Burlin O’Connell will set the strategic direction for the organization and ensure that Massachusetts life sciences companies have the best environment possible to research, develop, manufacture, and commercialize breakthrough therapies and cures for people around the world.
“Leading MassBio and supporting the collective efforts of our members to reshape global health is the honor of a lifetime,” said Kendalle Burlin O’Connell. “Our members have created the greatest life sciences ecosystem in the world. As their advocate and partner, our team at MassBio will ensure they have the tools and flexibility they need to identify the next life-changing breakthrough for patients.”
Pursuing innovation and delivering for members are hallmarks of Burlin O’Connell’s long tenure at MassBio. As she advanced through the organization, she launched several multi-year initiatives focused on realizing a diverse and equitable life sciences industry, supported the continued growth and sustainability of the sector throughout Massachusetts, and provided resources and solutions to companies across the industry value chain.
Burlin O’Connell has overseen the expansion of MassBio’s core programs and services, including the MassBioEdge, MassBio’s savings and rewards program,m and MassBio’shighly-ratedd Employee Rewards program. She also led the development of the MassBioHub conference and business center.
In 2022, Burlin O’Connell was instrumental in launching two initiatives focused on advancing breakthrough science and providing opportunities for innovators from diverse backgrounds in all areas of the life sciences ecosystem: MassBioDrive, the organization’s newest entrepreneurial accelerator program, and MassBio’s Innovation Week. She also built a professional relationship with Beacon Capital Partners that led to the creation of the MassBio workforce training center in Dorchester, which will open in 2023 and offer fast-track pathways to industry-aligned credentials and careers.
An influential and rising presence at the intersection of business and policy in Massachusetts, Burlin O’Connell 2022 was named a “Boston Power Player” by the media company Axios and received the Cambridge Chamber of Commerce Inspire Award recognizing outstanding women leaders in the Cambridge community. She was a 2021 executive fellow in the inaugural class of the Civic Action Project Collaborative, and a 2019 Boston Business Journal 40 under 40 honorees.
Burlin O’Connell currently serves as Vice-Chair of the Eastern New England Board of Directors for the American Cancer Society, Co-Chair of the 2022 New England ResearcHERS program, on the Board of Directors for the Massachusetts Biotechnology Education Foundation, and as an Advisory Committee member for the Suffolk University Law School All Rise Program.
She graduated cum laude from Sacred Heart University with a B.A. in Economics and Political Science and received her Juris Doctor from Suffolk University Law School.
About MassBio
MassBio’s mission is to advance Massachusetts’ leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. MassBio represents the premier global life sciences and healthcare hub, with 1,600+ members dedicated to preventing, treating, and curing diseases through transformative science and technology that brings value and hope to patients. Founded in 1985, MassBio works to advance policy and promote education, while providing member programs, events, industry information, and services for the world’s #1 life sciences cluster.
For more information: https://www.massbio.org/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.